Biotech companies stand as key actors in pharmaceutical innovation. The high risk and long timelines inherent with their R&D investments might hinder their access to funding, potentially stifling innovation. This study aims to explore into the appeal of biotech companies to capital market investors, whose financial backing could bolster the growth of the biotechnology sector.
Risk and Return in the Biotech Industry
GIACOMINI, Emanuela;
2023-01-01
Abstract
Biotech companies stand as key actors in pharmaceutical innovation. The high risk and long timelines inherent with their R&D investments might hinder their access to funding, potentially stifling innovation. This study aims to explore into the appeal of biotech companies to capital market investors, whose financial backing could bolster the growth of the biotechnology sector.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
10-1108_IJPPM-04-2023-0179.pdf
solo utenti autorizzati
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
DRM non definito
Dimensione
315.33 kB
Formato
Adobe PDF
|
315.33 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
